Compare NNNN & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | NCMI |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.2M | 376.1M |
| IPO Year | 2023 | 2006 |
| Metric | NNNN | NCMI |
|---|---|---|
| Price | $7.90 | $2.67 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 99.2K | ★ 1.3M |
| Earning Date | 04-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 52.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.20 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.61 | $2.16 |
| 52 Week High | $51.33 | $5.03 |
| Indicator | NNNN | NCMI |
|---|---|---|
| Relative Strength Index (RSI) | 37.25 | 35.52 |
| Support Level | N/A | $2.16 |
| Resistance Level | $13.01 | $3.87 |
| Average True Range (ATR) | 1.67 | 0.21 |
| MACD | -0.07 | -0.10 |
| Stochastic Oscillator | 18.56 | 24.37 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.